Skip to Main Content
Welcome to the Scientist.com Marketplace

Go to Main Navigation

FinVector

Website:
finvector.com
Headquarters:
Chinnor, England, GB
Company Type:
New Startup (0-1M TTM Revenue)

FinVector is a world leader in the research and development of Viral-Based Gene Therapy products. Our state-of-the-art facilities, highly experienced scientific team and commitment to work closely with clients every step of the way, have helped us to build an excellent reputation in the gene therapy market. We are authorised under EMA for the production of gene therapy products for clinical and commercial supply.

We offer services across a wide range of viral-based product types, including Adenoviral, AAV, and Lentiviral-based vectors. From our cutting-edge fully-licensed GMP manufacturing facility in Finland, we have built an extensive pipeline of gene therapy products and technologies for our clients.

Site Badges
FinVector
Oakley Road Chinnor, England, OX39 United Kingdom
FinVector
1 Microkatu Kuopio, , 70150 Finland
FinVector
Oakley Road , , OX39 4TW United Kingdom

Get started

If your organization has a Scientist.com marketplace, you can log in here to order products and services directly.

If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here.

To order products instantly, request access below.

Password must:

• Be at least 12 characters in length

• Contain a lowercase letter (a-z)

• Contain an uppercase letter (A-Z)

• Contain a numeral (0-9)

• Contain a special character (%, $, !, @)

By signing up for this account you agree to the Terms of Service